Novan, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 89
- Market Cap
- -
- Website
- http://www.novan.com
Clinical Trials
21
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 10.3% berdazimerDrug: vehicle gel
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 891
- Registration Number
- NCT04535531
- Locations
- 🇺🇸
Site #312, Glendale, Arizona, United States
🇺🇸Site #101, Hot Springs, Arkansas, United States
🇺🇸Site #272, Rogers, Arkansas, United States
A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 12%Drug: Placebo
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 355
- Registration Number
- NCT03927703
- Locations
- 🇺🇸
Site #266, Scottsdale, Arizona, United States
🇺🇸Site #101, Hot Springs, Arkansas, United States
🇺🇸Site #282, Beverly Hills, California, United States
A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: PlaceboDrug: SB206 12%
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 352
- Registration Number
- NCT03927716
- Locations
- 🇺🇸
Site #218, Mobile, Alabama, United States
🇺🇸Site #312, Glendale, Arizona, United States
🇺🇸Site #298, Little Rock, Arkansas, United States
A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
- Conditions
- Psoriasis
- Interventions
- Drug: SB414 6%Drug: Vehicle
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03445013
- Locations
- 🇺🇸
Novella Site# 247, Boise, Idaho, United States
🇺🇸Novella Site# 183, Austin, Texas, United States
🇺🇸Novella Site# 249, College Station, Texas, United States
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 8%Drug: SB206 12%Drug: PlaceboDrug: SB206 4%
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 256
- Registration Number
- NCT03436615
- Locations
- 🇺🇸
Premier Site# 266, Scottsdale, Arizona, United States
🇺🇸Premier Site# 260, Santa Ana, California, United States
🇺🇸Premier Site# 257, Thornton, Colorado, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next